Here we identified two tumours which were biallelically null for RB1 that also harboured focal MYCN amplifications, in the case of PD34256 an amplification of 168-fold, while PD37495 was amplified 51-fold (Table S7). This evidence concerns the gene MYCN and neoplasm.